Search research articles
Contact Us
Filters
Showing results (101-110 of 143) with videos related to
Page
of 15
Sort By:
Familial Cancer
|
August 8, 2015
POLE mutations in families predisposed to cutaneous melanoma
Lauren G Aoude, Ellen Heitzer, Peter Johansson, et al.
NPJ Breast Cancer
|
August 7, 2025
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2- breast cancer: insights and implications
Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, et al.
Therapeutic Advances in Medical Oncology
|
March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
Jakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Biomarker Research
|
December 1, 2024
Correction: Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay
Lilli Bonstingl, Margret Zinnegger, Katja Sallinger, et al.
Biomarker Research
|
November 16, 2024
Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: Unveiling resistance mechanisms with the CoDuCo in situ assay
Lilli Bonstingl, Margret Zinnegger, Katja Sallinger, et al.
ESMO Open
|
September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer
Samantha O Perakis, Sabrina Weber, Qing Zhou, et al.
British Journal of Cancer
|
January 9, 2026
Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility
Georgios Vlachos, Tina Moser, Isaac Lazzeri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer, Monika Artl, Martin Filipits, et al.
Journal of Translational Medicine
|
January 30, 2023
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines
Christina Karner, Ines Anders, Djenana Vejzovic, et al.
Clinical Chemistry
|
July 3, 2024
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For
Lilli Bonstingl, Christina Skofler, Christine Ulz, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 143) with videos related to
Sort By:
Page
of 15
Familial Cancer
|
August 8, 2015
POLE mutations in families predisposed to cutaneous melanoma
Lauren G Aoude, Ellen Heitzer, Peter Johansson, et al.
NPJ Breast Cancer
|
August 7, 2025
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2- breast cancer: insights and implications
Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, et al.
Therapeutic Advances in Medical Oncology
|
March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
Jakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Biomarker Research
|
December 1, 2024
Correction: Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay
Lilli Bonstingl, Margret Zinnegger, Katja Sallinger, et al.
Biomarker Research
|
November 16, 2024
Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: Unveiling resistance mechanisms with the CoDuCo in situ assay
Lilli Bonstingl, Margret Zinnegger, Katja Sallinger, et al.
ESMO Open
|
September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer
Samantha O Perakis, Sabrina Weber, Qing Zhou, et al.
British Journal of Cancer
|
January 9, 2026
Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility
Georgios Vlachos, Tina Moser, Isaac Lazzeri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer, Monika Artl, Martin Filipits, et al.
Journal of Translational Medicine
|
January 30, 2023
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines
Christina Karner, Ines Anders, Djenana Vejzovic, et al.
Clinical Chemistry
|
July 3, 2024
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For
Lilli Bonstingl, Christina Skofler, Christine Ulz, et al.
Page
of 15